Bruce Johnson, MD of the Dana-Farber Cancer Institute, Boston, MA has recently been elected as President of the American Society of Clinical Oncology (ASCO). At the 2016 Annual Meeting, he discussed one of his main goals to bring precision medicine from the academic centers to community practices, and provide physicians with the tools that will allow them to offer the best possible care to the patients that need it.